Datavault AI amends DataMeds deal to expand healthcare data license

Datavault AI Inc. (NASDAQ: DVLT) has amended its definitive agreement with DataMeds AI, Inc. (NASDAQ: MEDS) to expand a blockchain technology licensing relationship beyond pharmaceutical distribution to cover all commercial healthcare, healthspan, and wellness applications of Datavault AI's intellectual property, according to a press release.

Under the amended terms, Datavault AI will receive common shares representing approximately 19.9% of DataMeds common stock upon closing, replacing previously planned preferred shares. The change was made to optimize the transaction for tax purposes. The share issuance remains subject to closing conditions, including DataMeds' acquisition of two QOLPOM intellectual property portfolios from EOS Technology Holdings and a controlling interest in Tollo Health LLC from HighBridge Advisors. The value of the share issuance is expected to be categorized as revenue upon issuance.

DataMeds, formerly Wellgistics Health, Inc., completed a corporate name change on July 21, 2026, and began trading under the ticker symbol MEDS on the Nasdaq Capital Market on July 22, 2026. The company also announced a dividend of 50 Dream Bowl Meme Coin tokens per share of DataMeds common stock for holders of record as of August 7, 2026, subject to change at DataMeds' discretion.

The expanded agreement is intended to extend Datavault AI's data monetization and real-world asset tokenization technologies into DataMeds' healthcare data environment, covering pharmacy, medical, laboratory, and wearables settings.

"Datavault AI's platform gives us confidence that we can transform data into a strategic asset for our future customers," said Gerald Commissiong, Interim Co-CEO of DataMeds.

Nathaniel T. Bradley, CEO of Datavault AI, said the expansion into commercial healthcare and wellness represents "a natural next step for patient-controlled data."

According to figures cited in the press release from L.E.K. Consulting, healthcare data represents approximately 30% of global data volume and has been projected to grow at a compound annual rate of 36%.

You May Also Be Interested In

• Ferguson Enterprises to Join S&P 500; ADI Global Distribution to Join S&P SmallCap 600
• Grid Metals gets TSX Venture approval for cesium project joint venture
• Uni-Fuels receives Nasdaq minimum bid price deficiency notice